-
公开(公告)号:EP0849267A1
公开(公告)日:1998-06-24
申请号:EP97122290.6
申请日:1997-12-17
发明人: Mizukami, Tamio , Ogawa, Harumi , Nakai, Ryuichiro , Asai, Akira , Yamashita, Yoshinori , Ando, Katsuhiko , Agatsuma, Tsutomu , Akinaga, Shiro , Ouchi, Kozo , Kawasaki, Hideki
IPC分类号: C07D491/16 , A61K31/40 , C07D487/04 , C12P17/14 , C12N1/14
CPC分类号: C07D487/04 , C12P17/14
摘要: UCS1025 compounds represented by the following formula (I):
wherein R represents hydrogen or hydroxyl group, or tautomers or pharmacologically acceptable salts thereof.摘要翻译: 由下式(I)表示的UCS1025化合物或其互变异构体或其药理学上可接受的盐:其中R表示氢或羟基。
-
公开(公告)号:EP0768317A1
公开(公告)日:1997-04-16
申请号:EP96116414.2
申请日:1996-10-14
发明人: Mizukami, Tamio , Asai, Akira , Yamashita, Yoshinori , Katahira, Ritsuko , Hasegawa, Atsuhiro , Ochiai, Keiko , Akinaga, Shiro
CPC分类号: C07K5/06026 , A61K38/00
摘要: The present invention relates to UCK14 compounds having antitumor activity which are represented by the formula:
wherein R 1 is hydrogen or -COOC(CH 3 ) 3 ; and R 2 and R 3 are taken together to form -CH 2 -, or each R 2 and R 3 independently are hydrogen,
and pharmaceutically acceptable salts thereof.摘要翻译: 本发明涉及具有抗肿瘤活性的UCK14化合物,其由下式表示:其中R 1为氢或-COOC(CH 3)3; 并且R 2和R 3一起形成-CH 2 - ,或每个R 2和R 3独立地是氢,及其药学上可接受的盐。
-
公开(公告)号:EP0573976A1
公开(公告)日:1993-12-15
申请号:EP93109273.8
申请日:1993-06-09
发明人: Nakano, Hirofumi , Fujii, Noboru , Yamashita, Yoshinori , Uosaki, Youichi , Chiba, Shigeru , Katsumata, Shigeo , Tsuji, Yukari
摘要: A compound represented by formula (I):
or a pharmaceutically acceptable salt thereof is provided, which has an excellent antitumor activity.摘要翻译: 提供由式(I)表示的化合物:
或其药学上可接受的盐,其具有优异的抗肿瘤活性。
-
-